Delaware Judge Upholds $96 Million Patent Verdict in Natera Case Against CareDx

A Delaware federal judge has rejected Natera’s request for a new trial after a jury awarded the genetic testing company $96 million in damages. The case centered on allegations against CareDx, with the jury concluding that CareDx appropriated one of Natera’s patents. However, the jury found no infringement on a second patent held by Natera. This decision illustrates the complexities and nuances of legal battles in the patent space, where mixed outcomes can arise based on distinct patent claims and evidence presented. The judge’s decision underlines the sufficiency of the evidence supporting the original verdict. More details on this case can be found through Law360’s report.